RPG LifeScience.

65
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,778.10
-72.1 (-2.53%)
BSENSE

Jul 30, 03:30 PM

BSE+NSE Vol: 24.27 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'07
No of Months
12
12
12
Operating Income
707.00
653.00
130.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
9.00
Net Sales
707.00
653.00
120.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
8.00
3.00
Raw Materials Consumed
274.00
205.00
38.00
Power & Fuel Cost
18.00
17.00
3.00
Employee Cost
141.00
126.00
20.00
Operating Expenses
30.00
29.00
7.00
General and Administration Expenses
-1.00
-1.00
13.00
Selling and Distribution Expenses
31.00
35.00
5.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
18.00
11.00
7.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
559.00
492.00
98.00
Operating Profit (PBDIT) excl Other Income
147.00
160.00
22.00
Other Income
25.00
12.00
3.00
Operating Profit (PBDIT)
173.00
173.00
26.00
Interest
1.00
1.00
11.00
Profit before Depriciation and Tax
171.00
171.00
14.00
Depreciation
21.00
21.00
4.00
Profit Before Taxation & Exceptional Items
150.00
150.00
9.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
154.00
232.00
9.00
Provision for Tax
39.00
49.00
1.00
Profit After Tax
115.00
183.00
8.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
1.00
Profit Balance B/F
474.00
318.00
-10.00
Profit Available for appropriations
589.00
501.00
-1.00
Appropriations
589.00
501.00
-1.00
Equity Dividend (%)
300.00%
300.00%
15.00%
Earnings Per Share
69.64
110.80
5.75
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 8.28% vs NA in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -7.88% vs NA in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 11.32% vs NA in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -37.15% vs NA in Mar 2025

Compare Profit and Loss Results of RPG LifeScience.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
707.00
927.00
-220.00
-23.73%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
707.00
927.00
-220.00
-23.73%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
-22.00
1.00
4.55%
Raw Materials Consumed
274.00
447.00
-173.00
-38.70%
Power & Fuel Cost
18.00
14.00
4.00
28.57%
Employee Cost
141.00
136.00
5.00
3.68%
Operating Expenses
30.00
22.00
8.00
36.36%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
31.00
93.00
-62.00
-66.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
18.00
43.00
-25.00
-58.14%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
559.00
763.00
-204.00
-26.74%
Operating Profit (PBDIT) excl Other Income
147.00
164.00
-17.00
-10.37%
Other Income
25.00
73.00
-48.00
-65.75%
Operating Profit (PBDIT)
173.00
237.00
-64.00
-27.00%
Interest
1.00
12.00
-11.00
-91.67%
Profit before Depriciation and Tax
171.00
225.00
-54.00
-24.00%
Depreciation
21.00
33.00
-12.00
-36.36%
Profit Before Taxation & Exceptional Items
150.00
192.00
-42.00
-21.88%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
154.00
189.00
-35.00
-18.52%
Provision for Tax
39.00
54.00
-15.00
-27.78%
Profit After Tax
115.00
134.00
-19.00
-14.18%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
474.00
966.00
-492.00
-50.93%
Profit Available for appropriations
589.00
1,095.00
-506.00
-46.21%
Appropriations
589.00
1,095.00
-506.00
-46.21%
Equity Dividend (%)
300%
50%
250.00
Earnings Per Share
69.64
12.23
57.41
469.42%
Profit And Loss - Net Sales
Net Sales 707.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8.28% vs NA in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 147.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.88% vs NA in Mar 2025

Profit And Loss - Interest
Interest 1.77 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.32% vs NA in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 115.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -37.15% vs NA in Mar 2025